ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer.

Tina Cascone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.